Techbio is the utilisation of data-driven, digital technologies, in the research and production of life science-based inventions. Successful grant of a techbio patent requires cross-discipline expertise in biotechnology, and software and artificial intelligence (AI).
Appleyard Lees is a leading intellectual property law firm, with a wealth of experience supporting some of the world’s largest life sciences companies and research organisations. Our specialist team of techbio patent attorneys have the inter-disciplinary knowledge, and the strength-in-depth, to assist with large-scale patent filing and prosecution programmes. We have the expertise, flexibility and commercial knowledge required to effectively partner with in-house teams, providing strategic support at any point.
Techbio refers to data- and AI-driven life science research. Prior to the AI boom, this was often referred to as “bioinformatics”. Techbio often involves using software, statistics, algorithms and computational biology to analyse large datasets and accelerate research and development. Techbio innovations can be used to model, analyse and improve biological processes, speed-up drug discovery, or provide personalised medicine and diagnosis. Sometimes the innovation stemming from techbio companies is more on the tech side, and sometimes it is more on the bio side. In both cases, our techbio team has the expertise to help. Some examples of our expertise in this space are shown below, but we would be happy to discuss your specific R&D with you to identify your patentable innovations.
In G1/24 the Enlarged Board of Appeal of the EPO clarified that claims must be interpreted in light of the description when assessing patentability. However, it left open how this principle applies to added matter.
Read more
This article highlights the growing strength of unified European patent enforcement, the decisive impact of early legal action, and why innovative medical technology companies must be ready to act quickly when threatened by competitors.
Read more
Arnie Francis explores how recent CJEU case law has reshaped cross‑border patent enforcement. This is the first article in a three‑part series that explore long‑arm jurisdiction before the UPC.
Read more
Drawing on early decisions, Arnie Francis analyses how the UPC is applying long‑arm jurisdiction in practice. This is the second article in a three‑part series that explore long‑arm jurisdiction before the UPC.
Read moreIf you would like to discuss protection for your techbio innovation, please submit the following brief details:
Partner
MA (Hons), Mathematics; Masters, Computer Science, CPA, EPA
Julia has worked in the patent profession in the Cambridge area for over twenty-five years and in January 2017 she opened our Cambridge office. She oversees the patent portfolios for a wide variety of direct clients. Julia’s mathematics b…
Senior Associate
BSc(Hon), MSc, PhD, CPA, EPA, MRSB
Edward has experience assisting a wide variety of biotechnology and medical device companies to protect their innovations. Edward’s time working in academia helps him understand the needs of universities and spin-outs, when commercialisin…
